LifeMD (LFMD) vs Starling Oncology (STLN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Starling Oncology (STLN) has outperformed LifeMD (LFMD) over the past year, gaining 68.3% versus a loss of 57.9%. Over five years, STLN leads with a -35.4% price change compared with -46.1% for LFMD. Starling Oncology is the larger company by market cap ($639.0 million vs $127.9 million), about 5.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LFMD | STLN |
|---|---|---|
| Share price | $2.65 | $6.27 |
| Market cap | $127.88M | $639.01M |
| 1-day change | -5.00% | -2.49% |
| YTD return | -18.18% | +80.62% |
| 1-year return | -57.92% | +68.32% |
| 5-year return | -46.14% | -35.38% |
| Forward P/E | 6.97 | — |
| EPS (TTM) | $-0.51 | $-0.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.69 | $7.13 |
| 52-week low | $2.56 | $2.32 |
| Distance from 52-week high | -60.39% | -12.06% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +206.79% | +43.54% |
| Average volume | 836.48K | 1.54M |
| Shares outstanding | 48.26M | 101.92M |
| Employees | 347 | 641 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Starling Oncology is about 5.0 times larger than LifeMD by market value ($639.01M vs $127.88M).
- STLN has outperformed LFMD by 126.2 percentage points over the past year.
About LifeMD
LFMD stock →LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.
Health Care · Medical/Nursing Services · 347 employees
About Starling Oncology
STLN stock →Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.
Health Care · Medical/Nursing Services · 641 employees
LFMD vs STLN FAQ
Which is bigger, LifeMD or Starling Oncology?
Starling Oncology (STLN) is larger, with a market capitalization of $639.01M compared with $127.88M for LifeMD (LFMD).
Which stock has performed better over the past year, LFMD or STLN?
STLN returned +68.32% over the past 12 months, compared with -57.92% for LFMD (price return, excluding dividends). Past performance does not predict future results.
Are LifeMD and Starling Oncology in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.